Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood and Nerve Supply to the Bones01:29

Blood and Nerve Supply to the Bones

Bones are dynamic organs that require a rich supply of oxygen and nutrients. Around 5% to 10% of the cardiac output supplies blood to the bones. A typical long bone has three main sources: the nutrient artery, the metaphyseal and epiphyseal arteries, and the periosteal arteries.
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ready to Use Intravenous Ibuprofen in Adult and Paediatric Multimodal Perioperative Analgesia: European Clinical Expert Opinion.

Journal of pain research·2026
Same author

Efficacy and safety of intrathecal adjuvants in lower limb orthopaedic surgery: a systematic review and network meta-analysis of randomised controlled trials.

Journal of anesthesia, analgesia and critical care·2026
Same author

Perceptions of care quality and human rights in Italian outpatient facilities during and after the pandemic.

Frontiers in public health·2026
Same author

Consensus statement on mesotherapy for clinical and regulatory practice.

Rheumatology international·2026
Same author

Prehabilitation in oncological patients undergoing major gastrointestinal surgery: rationale and design of the PROGRESS trial.

Contemporary clinical trials·2026
Same author

Health-Related Quality of Life and Frequency of Depressive Episodes Among Healthcare Professionals in an Outpatient Health Facility in Italy: A Comparison Between 2017 (Pre-COVID) and 2025 (Post-COVID).

Journal of clinical medicine·2026

Related Experiment Video

Updated: Jun 23, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

Pain biomarkers.

Antonio Marchi1, Renato Vellucci, Sergio Mameli

  • 1Department of Anaesthesia and Resuscitation, University of Cagliari, Cagliari, Italy.

Clinical Drug Investigation
|May 19, 2009
PubMed
Summary
This summary is machine-generated.

Biomarkers show potential for identifying and quantifying pain, with different markers for inflammatory versus neuropathic pain. However, current research shows mixed results, necessitating further investigation for improved pain management.

More Related Videos

Spontaneous and Evoked Measures of Pain in Murine Models of Monoarticular Knee Pain
08:03

Spontaneous and Evoked Measures of Pain in Murine Models of Monoarticular Knee Pain

Published on: February 22, 2019

Human In-Vivo Bioassay for the Tissue-Specific Measurement of Nociceptive and Inflammatory Mediators
08:54

Human In-Vivo Bioassay for the Tissue-Specific Measurement of Nociceptive and Inflammatory Mediators

Published on: December 1, 2008

Related Experiment Videos

Last Updated: Jun 23, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

Spontaneous and Evoked Measures of Pain in Murine Models of Monoarticular Knee Pain
08:03

Spontaneous and Evoked Measures of Pain in Murine Models of Monoarticular Knee Pain

Published on: February 22, 2019

Human In-Vivo Bioassay for the Tissue-Specific Measurement of Nociceptive and Inflammatory Mediators
08:54

Human In-Vivo Bioassay for the Tissue-Specific Measurement of Nociceptive and Inflammatory Mediators

Published on: December 1, 2008

Area of Science:

  • Biomedical research
  • Pain science
  • Clinical diagnostics

Background:

  • Biomarkers are established tools for disease diagnosis and predicting treatment response.
  • The potential of biomarkers for pain identification and quantification is an emerging area of research.
  • Preclinical studies suggest distinct biomarkers for different pain types, such as inflammatory and neuropathic pain.

Purpose of the Study:

  • To explore the utility of biomarkers in identifying and quantifying pain.
  • To review existing evidence on the correlation between specific biomarkers and pain states.
  • To assess the potential of biomarkers for enhancing pain management strategies.

Main Methods:

  • Review of preclinical and clinical studies investigating pain biomarkers.
  • Analysis of findings related to cystatin C levels in cerebrospinal fluid for specific pain conditions.
  • Examination of cardiac markers in relation to chest pain and tissue damage.

Main Results:

  • Preclinical data indicates differential biomarkers for inflammatory and neuropathic pain.
  • Clinical findings are mixed: cystatin C shows predictive value for postherpetic neuralgia and acts as a pain marker in labor, but lacks correlation with pain intensity or duration.
  • Cardiac markers correlate with cardiac tissue damage, not directly with chest pain perception.

Conclusions:

  • Current evidence on pain biomarkers is inconsistent, highlighting the need for more research.
  • Specific biomarkers may hold promise for certain pain conditions, but their general applicability is limited.
  • Further investigation into pain biomarkers is crucial for advancing pain management practices.